DSM-Firmenich Makes Postbiotics Play With Adare Biome Deal
The potential for strong growth in the market for postbiotic products is the motivation behind DSM-Firmenich's €275m acquisition of France's Adare Biome.
The potential for strong growth in the market for postbiotic products is the motivation behind DSM-Firmenich's €275m acquisition of France's Adare Biome.